• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Active surveillance strategies to improve rates of inferior vena cava filter retrieval

byRhianna DavisandAlex Chan
April 19, 2023
in Cardiology, Hematology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this retrospective cohort study, rates of inferior vena cava (IVC) filter retrieval were improved when implanting physician teams adopted an active surveillance strategy. 

Evidence Rating Level 2: (Good)

Retrievable inferior vena cava filters are effective tools for the prevention of venous thromboembolism-related morbidity and mortality when anticoagulation is contraindicated. Retrievable IVC filters provide the greatest benefit to patients when removed within 90 days, with longer delays contributing to complications, such as filter fracture (up to 21%) and vessel or organ perforation (up to 12.4%). This retrospective cohort study assessed the medical records of 699 patients from a single institution with IVC filters placed between June 2011 and September 2019 to determine whether active surveillance by implanting physicians improved retrieval rates of IVC filters compared to passive surveillance. Prior to 2016, retrieval was organized passively via letters mailed to patients and physicians. Following 2016, physicians adopted an active surveillance model, whereby eligibility for retrieval was discussed with patients over the phone periodically by the implanting physician team. In this study, 55.2% of patients were followed by passive surveillance, and 44.8% were followed by active surveillance. With the adoption of active surveillance in 2016, filter retrieval increased from 48.7% to 61.4% per year, p<0.001. This study demonstrates that a significant increase in IVC filter removal was observed when the implanting physician team assumed the active surveillance model. This finding suggests that rates of IVC filter retrieval should improve if more physicians choose an active surveillance approach.

Click to read the study in JAMA Network Open

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

FDA grants priority review for iberdomide-based myeloma regimen

Tags: critical carehematologythromboembolism
Previous Post

Intranasal vaccine against Bordetella pertussis invokes seronegative IgA response

Next Post

#VisualAbstract: Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Variation noted across pre- and post-marketing studies for FDA approved devices
Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026
Obstetric scoring systems overestimate cases of severe sepsis
Infectious Disease

Fluoxetine may improve hemodynamic status and organ dysfunction in patients with severe sepsis

January 29, 2026
Next Post

#VisualAbstract: Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis

High incidence of cognitive impairment associated with colorectal cancer

Wellness Check: Spirituality

The 2 Minute Medicine Podcast Episode 11

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind April 27, 2026
  • Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke
  • Jennifer Aniston’s “Strength for 50+” ritual spotlights red light therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.